Menu

Top Stories

Published on Tuesday, February 26, 2019

The Alpha-1 Foundation gears up for the 2019 Global meetings in Dubrovnik, Croatia

The Alpha-1 Foundation gears up for the 2019 Global meetings in Dubrovnik, Croatia

MIAMI, Feb. 26th, 2019 - The 7th Alpha-1 Global Patient Congress and 4th International Research Conference on Alpha-1 Antitrypsin will be held April 3-6, at the Sheraton Dubrovnik Riviera Hotel in Dubrovnik, Croatia. Patient leaders, physicians and scientists from around the world will come together to discuss the latest developments in patient advocacy, clinical care and Alpha-1 Antitrypsin Deficiency (Alpha-1) research. 

With a rich history of international collaboration, the Foundation is committed to Alphas worldwide and is proud to host representatives from 32 countries. Through the dedication of the Conference Planning Committee, we are looking forward to another outstanding event. The commitment to the mission drives the Alpha-1 Global program each day, to increase awareness, detection, and access to care for Alphas around the world.  

“The recent changes in the Alpha-1 Global program offers me the opportunity to reshape our outreach to the entire Alpha-1 community, globally. Our strategic alliances are strong and will be reaffirmed in Dubrovnik, Croatia, at our International Scientific Conference and concurrent International Patient Congress. I would like to extend my gratitude to the Internal Conference Planning Committee, Richard Lovrich, who will be our emcee, and the Foundation’s hardworking staff and volunteers,” expressed Miriam O’Day, president and CEO of the Alpha-1 Foundation.

“These events will be the first international meetings I have attended since our meeting in Barcelona, in 2013. This is an exciting opportunity to be able to collaborate and strategize about the future of the Global program in my new role as president and CEO,” she added.

The 2019 meeting will begin with the 4th International Research Conference on Wednesday and Thursday, April 3-4. The Research Conference theme titled “Beyond Folding: Disease Progression and Therapeutic Options” is chaired by Professor Rob Stockley from University Hospitals Birmingham, United Kingdom. 

The program agenda for the 4th International Research Conference is available to view here

We will continue with representatives from 32 countries at the Global Patient Congress with a welcome reception and networking dinner where Alpha-1 patients, physicians and researchers can interact on Thursday, April 4th. The patient congress will continue Friday and Saturday, April 5-6.

The program agenda for the 7th Alpha-1 Global Patient Congress is available to view here

A special thank you to our outstanding Global Conference Planning Committee and Global Advisory Committee:

  • Cristina Barbiero, National Association Alfa-1 AT Italy, EU Advocacy Working Group, Italy
  • Jim Clarke, Alpha-1 Association New Zealand Co-Leader Alpha-1 Support Group, New Zealand
  • Shane Fitch, Lovexair Foundation - President, Spain
  • Elena Goyanes, Alpha-1 Association Spain, EU Advocacy Working Group, Spain
  • Karen O'Hara, Alpha-1 UK Support Group - ERN - Lung, EARCO, UK
  • Carlos Cambon, Alpha-1 Association Argentina, Argentina  
  • Martina Cambon, Alpha-1 Association Argentina, Argentina
  • Frank Willersinn, MD, Alpha-1 Plus, Belgium
  • Marion Bouchecareilh, University of Bordeaux, Alpha-1 Liver Research, France
  • Robert Durlik, Alpha-1 Poland, Founder, Poland
  • Robert Kroesen, Patient Representative, Panama
  • Tim Frost, AlphaNet Board Member, USA

Global Advisory Committee: 

  • Jeanine D’Armiento, MD, PhD, Alpha-1 Foundation – Chair, USA
  • Robert Sandhaus, MD, PhD, FCCP, Alpha-1 Foundation Medical Director, USA
  • Robert Stockley, MD, Director Lung Immuno Biochemical Research Laboratory, UK
  • Adam Wanner, MD, Alpha-1 Foundation Scientific Director, USA

The Alpha-1 Foundation graciously thanks the 2019 Alpha-1 Global Patient Congress and Research Conference Sponsors. Presenting Sponsors: AlphaNet, CSL Behring and Grifols. Gold Sponsors: Arrowhead, Kamada and Vertex. Bronze Sponsors: Dicerna and Mereo BioPharma.

CLICK HERE TO REGISTER TODAY

For additional information on the upcoming events, please contact Randel Plant, global programs manager, rplant@alpha1.org or 877-228-7321 ext. 306.

For hotel and travel arrangements, please contact Adriana De Arce, manager of scientific events, adearce@alpha1.org or 877-228-7321 ext. 269.


Print

Test gauges danger of rejection for children needing organ transplants

Thursday, November 20, 2014
This is a test: Write down the first thing that comes to your mind at the mention the word “transplant.” I’ll bet no one reading this column thought about pediatric liver or pediatric small- bowel transplants. But these...
Divider

Big changes for 2015 workplace plans: Watch out for 6 possible pitfalls

Wednesday, November 19, 2014
You don’t get a pass this year on big health insurance decisions because you’re not shopping in an Affordable Care Act marketplace. Employer medical plans — where most working-age folks get coverage — are changing...
Divider

Q&A: What's covered, what's not under Affordable Care Act

Monday, November 17, 2014
As the federal government and states launch a second round of enrollment under the healthcare law, consumers should be aware of what's covered and what's not when buying health coverage through insurance marketplaces. Plans cover essential health...
Divider

‘This is for every Alpha out there,’ Virginia woman says of Awareness Month proclamation

Friday, November 14, 2014
Sherry Gochenour, of Rockingham County, VA, was once a runner. Diagnosed with Alpha-1 three years ago, “now I can’t even walk to the mailbox,” she said in an interview broadcast Thursday on WHSV TV-3. In the...
Divider

Study explores way to diagnose bronchitis cause, prevent unnecessary antibiotic use

Wednesday, November 12, 2014
Antibiotics won't do an ounce of good for most cases of acute bronchitis, a nasty chest cold that can stir up a bone-jarring cough for months. Yet doctors prescribe the bacteria-killing drugs for as many as 70 percent of patients with the...
Divider

AASLD presentation: Alpha-1 polymers first biomarkers to show severity of liver disease

Wednesday, November 12, 2014
The level of alpha-1 ZZ protein polymers in the blood is the first biomarker found to indicate the severity of Alpha-1 liver disease, according to an abstract presented at the annual meeting of the American Association for the study of Liver...
Divider

Study: Immunotherapy promising in lung cancer survival time

Friday, October 31, 2014
Treatment of a common form of advanced lung cancer with the experimental immunotherapy nivolumab led to a one-year survival rate of 41 percent in a midstage clinical trial, according to data to be presented at a medical meeting. While the...
Divider

Portable ventilator cuts COPD symptoms, according to findings presented at CHEST meeting

Thursday, October 30, 2014
Assessment scores for chronic obstructive pulmonary disease (COPD) improved by more than 50 percent during treatment with a noninvasive open ventilation system (NIOV), results of a small prospective trial showed. The mean score on the modified...
Divider

States proclaim November 2014 Alpha-1 Awareness Month

Tuesday, October 28, 2014
Thanks to the efforts of support groups, officials in 23 states — and one city, Houston — have proclaimed November 2014 Alpha-1 Awareness Month. Great teamwork from the Alpha-1 community in reaching out and raising...
Divider

Foundation-funded study recruiting participants who use supplemental oxygen

Friday, October 10, 2014
Do you use supplemental oxygen? Are you using your oxygen less than the ideal amount of time? If so, you may be eligible to participate in a research study funded by the Alpha-1 Foundation.  A research team, led by Kristen Holm, PhD, at...
Divider

Jonathan Maidment recounts joys, challenges of Appalachian Trail hike in Hartford Courant story

Tuesday, October 7, 2014
Jonathan Maidment, who completed his trek of the Appalachian Trail on Sept. 17, is featured this week in a story in the Hartford Courant. Over the nearly seven-month journey, Maidment, 19, raised more than $30,000 for the Alpha-1...
Divider

Heleen Groen, of Amsterdam, tells about her long, life-threatening route to treatment

Friday, August 15, 2014
Heleen Groen, 40, of Amsterdam, Netherlands, is an Alpha who has severe necrotizing panniculitis, a painful skin infection often accompanied by a rash, inflammation and skin ulcers. She shares her experience of growing up with Alpha-1 and...
Divider
First55565758596061626364Last

Article Search

Enter keywords in text box and click Search button for results.

Archive